Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

ClinicalTrials.gov ID: NCT00106808

Public ClinicalTrials.gov record NCT00106808. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar (BMS-298585) Compared to Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Study identification

NCT ID
NCT00106808
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,440 participants

Conditions and interventions

Interventions

  • Muraglitazar Drug
  • Pioglitazone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Jul 31, 2006
Completion
Jul 31, 2006
Last update posted
Sep 13, 2010

2005 – 2006

United States locations

U.S. sites
112
U.S. states
31
U.S. cities
112
Facility City State ZIP Site status
Local Institution Birmingham Alabama
Local Institution Columbiana Alabama
Local Institution Madison Alabama
Local Institution Glendale Arizona
Local Institution Mesa Arizona
Local Institution Peoria Arizona
Local Institution Phoenix Arizona
Local Institution Scottsdale Arizona
Local Institution Beverly Hills California
Local Institution Concord California
Local Institution Encinitas California
Local Institution Fresno California
Local Institution La Jolla California
Local Institution Los Angeles California
Local Institution Los Gatos California
Local Institution Orange California
Local Institution Pasadena California
Local Institution Roseville California
Local Institution Santa Monica California
Local Institution Colorado Springs Colorado
Local Institution Wilmington Delaware
Local Institution Boynton Beach Florida
Local Institution Charlotte Harbour Florida
Local Institution Chipley Florida
Local Institution Destin Florida
Local Institution Holly Hill Florida
Local Institution Jacksonville Florida
Local Institution Miami Florida
Local Institution New Port Richey Florida
Local Institution Niceville Florida
Local Institution Panama City Florida
Local Institution Port Charlotte Florida
Local Institution Atlanta Georgia
Local Institution Blue Ridge Georgia
Local Institution Calhoun Georgia
Local Institution Carrollton Georgia
Local Institution Dunwoody Georgia
Local Institution Marietta Georgia
Local Institution Chicago Illinois
Local Institution North Chicago Illinois
Local Institution Evansville Indiana
Local Institution Indianapolis Indiana
Local Institution Shawnee Mission Kansas
Local Institution Wichita Kansas
Local Institution Louisville Kentucky
Local Institution Lafayette Louisiana
Local Institution Shreveport Louisiana
Local Institution Baltimore Maryland
Local Institution Cantonville Maryland
Local Institution Towson Maryland
Local Institution Westminister Maryland
Local Institution Swansea Massachusetts
Local Institution Cadillac Michigan
Local Institution Portage Michigan
Local Institution Richland Michigan
Local Institution Gulfport Mississippi
Local Institution Tupelo Mississippi
Local Institution City of Saint Peters Missouri
Local Institution Excelsior Springs Missouri
Local Institution Butte Montana
Local Institution Missoula Montana
Local Institution Bridgewater New Jersey
Local Institution Cherry Hill New Jersey
Local Institution Binghamton New York
Local Institution Johnson City New York
Local Institution Mineola New York
Local Institution Northport New York
Local Institution Charlotte North Carolina
Local Institution Greenville North Carolina
Local Institution Hickory North Carolina
Local Institution Morehead City North Carolina
Local Institution Salisbury North Carolina
Local Institution Wilmington North Carolina
Local Institution Barberton Ohio
Local Institution Bellbrook Ohio
Local Institution Canal Fulton Ohio
Local Institution Canfield Ohio
Local Institution Canton Ohio
Local Institution Columbus Ohio
Local Institution Lyndhurst Ohio
Local Institution Mentor Ohio
Local Institution Youngstown Ohio
Local Institution Eugene Oregon
Local Institution Medford Oregon
Local Institution Portland Oregon
Local Institution Philipsburg Pennsylvania
Local Institution Pittsburgh Pennsylvania
Local Institution Reading Pennsylvania
Local Institution Tipton Pennsylvania
Local Institution West Grove Pennsylvania
Local Institution East Providence Rhode Island
Local Institution Greer South Carolina
Local Institution Mt. Pleasant South Carolina
Local Institution Simpsonville South Carolina
Local Institution Chattanooga Tennessee
Local Institution Fayetteville Tennessee
Local Institution Memphis Tennessee
Local Institution Selmer Tennessee
Local Institution Austin Texas
Local Institution Corpus Christi Texas
Local Institution Houston Texas
Local Institution Irving Texas
Local Institution Midland Texas
Local Institution New Braunfels Texas
Local Institution Pearland Texas
Local Institution Rosenberg Texas
Local Institution San Antonio Texas
Local Institution Bountiful Utah
Local Institution Falls Church Virginia
Local Institution Norfolk Virginia
Local Institution Salem Virginia
Local Institution Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 13, 2010 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00106808 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →